Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 19:15:153.
doi: 10.1186/s12885-015-1168-2.

Total and partial cancer prevalence in the adult French population in 2008

Marc Colonna  1   2 , Nicolas Mitton  3 , Nadine Bossard  4   5   6   7 , Aurelien Belot  8   9   10   11   12   13 , Pascale Grosclaude  14 ; French Network of Cancer Registries (FRANCIM)
Affiliations

Total and partial cancer prevalence in the adult French population in 2008

Marc Colonna et al. BMC Cancer. .

Abstract

Background: To provide estimations of partial and total prevalence of 24 cancer sites in France in 2008. The estimations of partial prevalence were compared with the previous estimations for 2002.

Methods: Nationwide estimations of incidence and survival data from cancer registries were used for partial prevalence. Nationwide incidence and mortality data were used to estimate total prevalence.

Results: At the end of 2008, in France, nearly 3 million people still alive had received a diagnosis of cancer. Of all prevalent cases, 36% were diagnosed 0 to 5 years earlier and 43% diagnosed 6 to 10 years earlier. The cancer sites with the highest prevalence were the prostate, the breast, and the colon-rectum. The changes in partial prevalence over 5 years (2002 to 2008) were considerable (+244,000 cases) and deemed to be highly related to changes in incidence.

Conclusion: The present estimations update the French prevalence data and highlight the burden of cancer in the population, especially in the elderly. The methods of this study had the advantage of using recent incidence and survival data, which is necessary to show sudden changes in incidence trends and changes in survival that impact prevalence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Breakdown of the prevalent cases at 10 years in men according to the time since diagnosis (France, 2008).
Figure 2
Figure 2
Breakdown of the prevalent cases at 10 years in women according to the time since diagnosis (France, 2008).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Giles G. How important are estimates of cancer prevalence? Ann Oncol. 2002;13:815–6. doi: 10.1093/annonc/mdf204. - DOI - PubMed
    1. Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman M, Hakulinen T, et al. Cancer prevalence in European registry areas. Ann Oncol. 2002;13:840–65. doi: 10.1093/annonc/mdf127. - DOI - PubMed
    1. Colonna M, Danzon A, Delafosse P, Mitton N, Bara S, Bouvier AM, et al. Cancer prevalence in France: Time trend, situation in 2002 and extrapolation to 2012. Eur J Cancer. 2008;44:115–22. doi: 10.1016/j.ejca.2007.10.022. - DOI - PubMed
    1. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, et al. NORDCAN – a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49:725–36. doi: 10.3109/02841861003782017. - DOI - PubMed
    1. Crocetti E, De Angelis R, Buzzoni C, Mariotto A, Storm H, Colonna M, et al. Cancer prevalence in USA, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability. Br J Cancer. 2013;109:219–28. doi: 10.1038/bjc.2013.311. - DOI - PMC - PubMed

LinkOut - more resources